Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Symptomatic Venous Thromboembolism (VTE)
Clinical Trial
NCT07213778Last updated: 1/7/2026
REGN
Regeneron Pharmaceuticals, Inc.